ArticleInfection2025
Neonatal central nervous system infection by Ureaplasma species is rare, but relevant: results from a multicenter nationwide surveillance study.
Article in Infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cord blood procalcitonin and soluble urokinase-type plasminogen activator receptor in predicting histological chorioamnionitis - A pilot study.European journal of obstetrics & gynecology and reproductive biology: X · 2026Article
- [Advances in clinical pharmacotherapy for neonatalZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025Review
- Antimicrobial susceptibility and genetic mechanisms of resistance ofAntimicrobial agents and chemotherapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeUreaplasma species (spp.) are relevant contributors to preterm birth but may also cause invasive infections particularly in very immature preterm infants. This study aimed to assess the incidence of neonatal Ureaplasma infections of the central nervous system (CNS).
methodsA nationwide epidemiological study on Ureaplasma CNS infection in preterm and term neonates and infants below 12 months of age was conducted between 10/2019 and 09/2022, using the German Pediatric Surveillance Unit (ESPED).
resultsOver a period of three years, five infants with Ureaplasma meningitis were reported, amended by three cases treated in our own hospital. All infants had a history of extreme preterm birth. Clinical presentation varied and included non-specific neurological symptoms, such as developmental delay, in some cases, and acute, sepsis-like conditions in others, with increased apneas, irritability, and seizures. As the most consistent finding, internal hydrocephalus was reported, paralleled by pathological cerebrospinal fluid assessment characterized by mild pleocytosis, persistently elevated protein levels, and remarkably low or undetectable glucose levels, prompting further diagnostics. Treatment protocols varied and included off-label regimens. Ureaplasma eradication was verified by negative CSF-PCR and/or culture in most cases. Despite successful eradication, long-term neurological impairment was present in all infants.
conclusionAlthough seemingly rare, Ureaplasma-driven neuroinflammation relevantly contributes to long-term morbidity of affected preterm infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.